Introduction
The visual prognosis of patients with optic neuritis has been well studied by the Optic Neuritis Treatment Trial (ONTT). [1] [2] [3] Benefit from treatment with intravenous steroid in prevention from multiple sclerosis (MS) has also been extensively analyzed. [4] [5] [6] [7] However, these studies were mostly confined to young adults. Optic neuritis in children is considered to be a totally different entity in contrast to adults. Children with optic neuritis usually experience better visual recovery, they also have more bilateral involvement and optic disc swelling, and carry a relatively low risk of subsequent MS as well. [8] [9] [10] However, there have been accumulating reports with different clinical characteristics of optic neuritis and MS in Europe, 11, 12 North America, 8, 9, 13 and Asia. [14] [15] [16] [17] Herein we report a retrospective study to evaluate the clinical characteristics of children with optic neuritis in Taiwan. Meanwhile, the specific aim of this study was to statistically document the factors relevant to visual prognosis in optic neuritis in children.
Patients and methods
The medical records of all patients younger than 18 years old, who came to Linkou Chang Gung Memorial Hospital and Chang Gung Children's Hospital from 1998 to 2009, with a diagnosis of optic neuritis were retrospectively reviewed. This study was approved by the Institutional Review Board at Chang Gung Memorial Hospital. The diagnosis of optic neuritis was made on the basis of history of visual loss and some of the clinical findings including afferent pupillary defect, visual field defect, optic disc appearance, color vision defect, and abnormal visual-evoked potentials. Patients with hereditary optic neuropathy, systemic vascular diseases, compressive optic neuropathy, and malignancy were excluded from this study. Optic neuritis was recorded as unilateral or bilateral. Bilateral simultaneous disease was defined as both eyes being affected within 1 month of each other, and bilateral recurrent disease was defined as one or both eyes being affected more than once.
Information about the sex, age of onset, laterality (unilateral or bilateral), initial visual acuity (VA), final VA, cerebrospinal fluid (CSF) findings, therapy, recent infections and immunizations, image study including computer tomography (CT) or magnetic resonance imaging (MRI), and associated systemic diseases such as MS or acute disseminated encephalomyelitis (ADEM) was obtained.
For statistical analysis, the initial VA and final VA were taken as best-corrected VA (BCVA). A logarithmic transformation of decimal VA was used a scattergram. Eyes without formed vision were classified into one of four low-vision categories, which were assigned decimal equivalents as follows: counting fingers ¼ 0.00500; hand motion ¼ 0.00250; light perception ¼ 0.00125; and no light perception ¼ 0.00100. 18 The logarithm of reciprocal decimal VA was used to approximate the logarithm of minimal angle of resolution (log MAR). All statistical analyses were conducted using SPSS software (Standard Windows version 15.0, SPSS, Chicago, IL, USA). All P-values quoted were two-tailed and were considered statistically significant when they were less than 0.05. Table 1 , 24 patients (38 eyes) were included in this study; their ages ranged from 5 to 17 years. The mean age at presentation was 10.08±4.15 years. Follow-up period ranged from 1 week to 12 years, with a mean of 14.01 months (median: 2.5 months). There were 14 female patients (58.3%) and 10 male patients (41.7%). Fourteen patients (58.3%) had bilateral disease, and ten patients (41.7%) had unilateral disease. In addition, 14 patients (58.3%) had afferent pupillary defect, and 24 eyes (63.2%) had disc swelling. Of mg/kg/day) for 3-5 days, and followed by oral prednisolone 1 mg/kg/day for 2-4 weeks, the other 2 patients received dexamethasone therapy (5 mg, q6 h for 7 days, followed by tapering from q8 h, q12 h to qd). Of 10 patients (41.7%) performed CSF analysis, 8 patients had normal CSF findings. Of seven patients further tested for oligoclonal band in CSF and calculated IgG index, none had oligoclonal band. One patient had IgG index over 0.66 (0.792) and developed MS. In addition, two patients diagnosed with ADEM had proof of recent viral infection by CSF study and by serological test, respectively. These details of patients' information are summarized in Table 2 . Intravenous dexamethasone (5 mg) q6 h for 7 days, followed by q8 h for 2 days, q12 h for 2 days, and qd for 2 days. c Normal IgG indexo0.66. Intravenous dexamethasone (5 mg) q6 h for 7 days, followed by q8 h for 2 days, q12 h for 2 days, and qd for 2 days. c Recurrent two times. 
Results

As shown in
Effect of disc appearance on final VA
The values of final VA (logMAR) in the three groups were significantly different (P ¼ 0.025, Kruskal-Wallis test). Non-parametric post-hoc comparisons indicated that final VA in the pale disc group was significantly poorer than that in the swelling disc group (P ¼ 0.016) and normal disc group (P ¼ 0.022). There was no difference in final VA between the swelling disc group and normal disc group (P ¼ 0.352) (Mann-Whitney U-test). Out of 24 eyes, 20 (83.3%) with swelling disc at presentation achieved final VA of 20/40 or better, 9 of 11 eyes (81.8%) with normal disc at presentation achieved final VA of 20/40 or better, and none of 3 eyes (0%) with pale disc at presentation attained final VA of 20/40 or better. There was a statistically significant trend toward a poorer visual outcome in eyes with pale disc at presentation (P ¼ 0.005, Pearson w 2 -test).
Effect of age at presentation on final VA
Subgroup analysis was performed on the visual outcome in patients 10 years of age or younger and those 11 years of age or older at presentation. All of the 15 patients (100%) who were 10 years of age or younger achieved final VA of 20/40 or better; five of nine patients (55.6%) who were 11 years of age or older achieved final VA of 20/40 or better. There was a statistically significant better visual outcome in children younger than 10 years of age (P ¼ 0.012, Fisher's exact test).
Effect of systemic association on final VA
Five patients were diagnosed with ADEM, and four of these five patients (80%) achieved final VA of 20/40 or better. Three patients were diagnosed with MS, and two of these three patients (66.7%) attained final VA of 20/40 or better. Statistical analysis for visual outcome in ADEM vs MS group, and patients with ADEM vs patients without ADEM demonstrated that there were no significant difference (P ¼ 0.643, and 0.635, respectively, Fisher's exact test).
Regression analysis for final VA
We further divided patients into unilateral and bilateral groups for assessment of all above factors in final VA. In the unilateral group, there is a significant relationship between age and final VA, with a 1-year increase in age being associated with an increase of 0.034 log MAR in final VA (P ¼ 0.013, multiple linear regression analysis) after adjusting for initial VA. Meanwhile, the relationship between disc appearance at presentation and final VA is highly significant in the bilateral group, with a decrease of 1.646 log MAR in final VA in normal disc group (P ¼ 0.001) and a decrease of 1.489 log MAR in final VA in swelling disc group (P ¼ 0.002), after adjusting for initial VA (multiple linear regression analysis).
Neuroimaging
Of 24 patients, MRI of the brain was performed in 19 patients. Computed tomography of the brain was performed in three patients. Out of 19 patients, 11 (57.89%) had abnormal MRI findings, including only optic nerve enhancement in 2 patients, combined optic nerve enhancement with cerebral white matter lesion in 2 patients, and multiple cortical white matter lesions in the brain or spinal cord in 7 patients. In eight patients with normal MRI of the brain, the images all revealed well visualization of bilateral optic nerve and optic pathway without definite abnormal signal intensity or contrast enhancement. Interestingly, of these eight patients with normal optic nerve appearance in MRI, five patients (62.5%) had disc swelling, and the other three patients (37.5%) had normal optic disc. In contrast, of four patients having abnormal enhancement of optic nerve in MRI in this study, two patients (50%) had disc swelling and the other two patients (50%) had normal optic disc. Taken together, it indicated that appearance of optic disc might not correlate well with optic nerve appearance in image study. Of 11 patients having abnormal MRI findings, 8 patients (72.7%) achieved final VA of 20/40 or better. All three patients performing CT of the brain had normal findings. Of a total 11 patients having normal image study (MRI or CT), 10 patients (90.9%) achieved final VA of 20/40 or better. There was a trend toward better visual outcome in children with normal image study, but there was no statistically significant difference (P ¼ 0.586, Fisher's exact test). The factors for visual prognosis in pediatric optic neuritis in this study are summarized in Table 3 .
Discussion
The visual prognosis and clinical features of pediatric optic neuritis has been described previously. 8, 11, 12, 14, 15, 17, 19 According to these reports, 77-90% of patients attained final VA of 20/40 or better. In addition, optic neuritis in childhood had more bilateral, female involvement, disc swelling at presentation, and was frequently associated with preceding viral infection. In our study, 83.3% of our patients achieved final VA of 20/40 or better, suggesting favorable visual recovery in Taiwanese children. Our study further confirms previous clinical features of optic neuritis in children such as more bilateral, female involvement and disc swelling at presentation (Table 4 ). However, older mean age, lower preceding febrile illness, and a relatively lower development rate of MS were noted in Taiwanese children. ADEM is the most common associated systemic disease in current study. Accumulating evidences have reported some factors relevant to better visual outcome in pediatric optic neuritis. For instance, unilateral involvement, 9 normal MRI of the brain, and children 6 years of age or younger appeared to have a better visual prognosis. 8 Compared with a previous study, there was no significant difference in visual outcome between children with unilateral involvement and bilateral involvement in our study. Although we also found a trend toward children with normal image study seeming to have a better visual outcome, there was no statistically significant difference. Nevertheless, we demonstrated that children younger than 10 years old significantly had a better visual prognosis. Furthermore, the younger the age, the better the final VA was in children with unilateral involvement as shown by regression analysis.
Optic atrophy has been identified in 85% of pediatric optic neuritis and does not have a strict correlation with VA. 20 In our study, we found that children with pale disc at presentation significantly had a poorer visual outcome than children with normal or swelling optic disc at presentation. In addition, we also found that disc changes at presentation in bilateral disease were more important for predicting final VA. Patients with pale disc at presentation significantly had poor final VA; it is possible that pale disc at presentation might result from a previous unknown episode of optic neuropathy or delayed diagnosis of optic neuritis. In this study, one patient (number 18) experienced three episodes of optic neuritis in each eye. This patient ended up with pale optic disc and showed less favorable visual recovery compared with the other two patients (number 6 and 7) who experienced two episodes of optic neuritis. Therefore, the number of attacks of optic neuritis might be also an important factor for less favorable visual recovery. However, significant improvement of final vision was noted in most of our patients, regardless of initial vision, indicating the nature of better visual recovery in pediatric optic neuritis.
ADEM is a monophasic, multifocal, inflammatory disease of the central nervous system, and is considered to be a demyelinating illness of probable autoimmune etiology. It often occurs after recent viral infections or vaccination, 21 but it can also develop without an apparent preceding condition. 22 The acute neurological signs and symptoms may include headache, fever, vomiting, altered level of consciousness, seizures, motor and/or sensory deficits, cerebellar ataxia, and cranial nerve palsy. 23, 24 Of five patients with ADEM in our study, two patients (40%) had fever, one patient (20%) had seizure, and two patients (40%) had preceding viral infection. Optic neuritis is not uncommon in children with ADEM. 25, 26 Optic neuritis in children with ADEM often is bilateral and associated with optic disc edema. 27, 28 Meanwhile, the efficacy of intravenous steroid therapy was proved to be beneficial for ADEM. 23, 24, 26, 29 Excellent response to steroid therapy in visual improvement and reduction of demyelinating lesions on MRI without recurrence in children with ADEM have also been reported. 27, 28, 30 In our study, disc swelling at presentation was noted in three of five patients (60%) with ADEM, and bilateral optic neuritis was noted in two of five patients (40%) with ADEM. In addition, all of the patients with ADEM received steroid pulse therapy. Four of five patients (80%) with ADEM achieved final VA of 20/20, and the other one patient achieved a final VA of 20/50. Our results seem to be comparable to previous reports. However, the limitation of our study was that most of our patients received intravenous steroid pulse therapy and there was no control group for comparison. It is still unknown whether intravenous steroid pulse therapy had a beneficial effect on visual recovery in pediatric optic neuritis, and in pediatric optic neuritis with ADEM.
The risk for developing MS after optic neuritis in children has been well studied. Lucchinetti et al 31 reported that 13% of the patients with isolated optic neuritis had progressed to clinically or laboratorysupported definite MS by 10 years of follow-up, 19% by 20 years, 22% by 30 years, and 26% by 40 years. Meanwhile, the presence of bilateral sequential or recurrent optic neuritis increased the risk of developing MS. In addition, the presence of HLA-DR2 antigens, 11 and unilateral disease have also been reported to be the other risk factors. 9, 11 However, the rate of developing MS after pediatric optic neuritis also varied with race (Table 4 ). In comparison with other Asian countries, the rate of developing MS was 12.5% in our study, which was higher than Korean (4%), 15 and Thai (9.1%), 14 but was much lower than that reported in Japanese (31.7%), 17 and another recent Korean study (25%). 19 One of the reasons for wide range of conversion rate in each study might be due to different follow-up period. Two of three patients who developed MS in our study had concurrent bilateral papillitis, the third patient had bilateral sequential and recurrent retrobulbar optic neuritis. Our finding was compatible with the observation from previous reports. 8, 31 In this study, all these three patients with MS had bilateral optic neuritis, indicating that a bilateral disease might be a risk factor for developing MS.
